Surviving cancer: Do psychosocial factors count? Editorial

Journal of Psychosomatic Research

Volumn 47, Issue 6, 1999, Pages 497-503

  Walker, Leslie G ^a   Heys, Steven D ^b   Eremin, Oleg ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; DEPRESSION; EDITORIAL; HUMAN; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SUPPORT GROUP; TUMOR IMMUNITY;

HUMANS; IMAGERY (PSYCHOTHERAPY); NEOPLASMS; PSYCHONEUROIMMUNOLOGY; PSYCHOTHERAPY, GROUP; RANDOMIZED CONTROLLED TRIALS; RELAXATION TECHNIQUES; SOCIAL SUPPORT; SURVIVAL ANALYSIS; SURVIVORS;

EID: 0033402915     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(99)00060-4     Document Type: Editorial

References (57)

1. Goldfarb C., Driesen J., Cole D. Psychophysiologic aspects of malignancy. Am J Psychiatry. 123:1967;1545-1552.
2. Paget J. Surgical pathology. 1870;Longman Green, London.
3. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., Gale R.P. Stress increases metastatic spread of a mammary tumor in rats. evidence for mediation by the immune system Brain Behav Immunol. 5:1991;193-205.
4. Watson M., Ramirez A. Psychological factors in cancer prognosis. Cooper C.L., Watson M. Cancer and stress. psychological, biological and coping studies:1991;John Wiley & Sons, Chichester, UK.
5. Hilakivi-Clarke L., Rowland J., Clarke R., Lippman M.E. Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat. 29:1994;141-160.
6. Chen C.C., David A.S., Nunnerly H., Mitchell M., Dawson J.L., Berry H., Dobbs J., Berry H. Adverse life events and breast cancer. a case controlled study BMJ. 311:1995;1527-1530.
7. Courtney J.G., Longnecker M.P., Theorell T., Gerhardsson de Verdier M. Stressful life events and the risk of colorectal cancer. Epidemiology. 4:1993;407-414.
8. Ginsberg A., Price S., Ingram D., Nottage E. Life events and the risk of breast cancer; a case control study. Eur J Cancer. 32A:1996;2049-2052.
9. Roberts F.D., Newcomb P.A., Trentham-Dietz A., Storer B.E. Self reported stress and risk of breast cancer. Cancer. 79:1997;1055-1059.
10. Fox B.H. Current theory of psychogenic effects on cancer incidence and prognosis. J Psychosoc Oncol. 1:1983;17-31.
11. Fox B.H. The role of psychological factors in cancer incidence and progression. Oncology. 9:1995;245-253.
12. Barraclough J., Pinder P., Cruddas M., Osmond M., Taylor A.N., Perry M. Life events and breast cancer prognosis. BMJ. 304:1992;1078-1081.
13. Barraclough J., Osmond M., Taylor A.N., Perry M., Collins P. Life events and breast cancer prognosis. BMJ. 307:1993;325.
14. Ramirez A.J., Craig T.J.K., Watson J.P., Fentiman I.S., North W.R.S., Rubens R.D. Stress and relapse of breast cancer. BMJ. 298:1989;191-193.
15. Ramirez A.J., Richards M.A., Gregory W.M., Craig T.J.K., Watson J.P., Fentiman I.S. Life events and breast cancer prognosis. BMJ. 304:1992;1632.
16. Greer S., Morris T., Pettingale K.W., Haybittle J.L. Psychological response to breast cancer and 15 year outcome. Lancet. 335:1990;49-50.
17. Pettingale K.W., Morris T., Greer S., Haybittle J.L. Mental attitudes to cancer. an additional prognostic factor Lancet. i:1985;750.
18. Spiegel D., Kato P.M. Psychosocial influences on cancer incidence and progression. Harvard Rev Psychiatry. 4:1996;10-26.
19. Maunsell E., Brisson J., Deschennes L. Social support and survival among women with breast cancer. Cancer. 76:1995;631-637.
20. Spiegel D., Sephton S.E., Terr A.I., Stites D.P. Effects of psychosocial treatment in prolonging cancer survival may be mediated by immune pathways. Ann NY Acad Sci. 840:1998;674-683.
21. Spiegel D., Bloom J.R., Kraemer H.C., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. ii:1989;889-891.
22. Kogan M.W., Biswas A., Pearl D., Carlson R.W., Spiegel D. Effects of medical and psychotherapeutic treatment on the survival of women with breast carcinoma. Cancer. 80:1997;225-230.
23. Fox B.H. A hypothesis about Spiegel et al.'s 1989 paper on psychosocial intervention and breast cancer survival. Psycho-Oncol. 7:1998;361-370.
24. Fox B.H. Rejoinder to Spiegel et al. Psycho-Oncol. 7:1998;518-519.
25. Spiegel D., Kraemer H.C., Bloom J.R. A tale of two methods. randomization versus matching trials in clinical research Psycho-Oncol. 7:1998;371-375.
26. Fawzy F.I., Fawzy N., Hyun L.S., Elashoff R., Guthrie D., Fahy J.L., Morton D.L. Malignant melanoma. effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later Arch Gen Psychiatry. 50:1993;681-689.
27. Richardson J.L., Shelton D.R., Krailo M., Levine A.M. The effect of compliance with treatment on survival among patients with haematologic malignancies. J Clin Oncol. 80:1990;356-364.
28. Ratcliffe M.A., Dawson A.A., Walker L.G. Eysenck Personality Inventory L-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Psycho-Oncol. 4:1995;39-45.
29. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatry Scand. 67:1983;361-370.
30. Eysenck H.J., Eysenck S.B.G. Manual of the Eysenck Personality Scales (EPS Adult). 1991;Hodder & Stoughton, London.
31. Walker L.G. Hypnosis and cancer. host defences, quality of life and survival Contemp Hypnos. 15:1998;34-39.
32. Gellert G.A., Maxwell R.M., Siegel B.S. Survival of breast cancer patients receiving adjunctive psychosocial support therapy. a 10 year follow-up study J Clin Oncol. 11:1993;66-69.
33. Ilnyckyj A., Farber J., Cheang M.et al. A randomised controlled trial of psychotherapeutic interventions in cancer patients. Ann R Coll Phys Surg Can. 27:1994;93-96.
34. Linn M.W., Linn B.S., Harris R. Effects of counselling for late stage cancer patients. Cancer. 49:1982;1048-1055.
35. Cunningham A.J., Edmonds C.V.I., Jenkins G.P., Pollack H., Lockwood G.A., Warr D. A randomised controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-Oncol. 7:1998;508-517.
36. Cunningham A.J. An experimental approach to the mind/cancer question. Adv J Mind-Body Health. 12:1996;58-62.
37. Dreher H. The scientific and moral imperative for broad-based psychosocial interventions for cancer. Adv J Mind-Body Health. 13:1997;38-49.
38. Goodwin P.J., Leszcz M., Koopmans J., Arnold A., Doll R., Chochinov H., Navarro M., Butler K., Pritchard K.I. Randomised trial of group psychosocial support in metastatic breast cancer. the BEST study. Breast-Expressive Supportive Therapy Cancer Treat Rev. 22(suppl A):1996;91-96.
39. Lewis C.E., O'Sullivan C., Barraclough J. The psychoimmunology of cancer. 1994;Oxford University Press, Oxford, UK.
40. Walker L.G., Eremin O. Psychoneuroimmunology. a new fad or the fifth cancer treatment modality Am J Surg. 170:1995;2-4.
41. Ader R., Felten D.E.L., Cohen N. Psychoneuro-immunology. 2nd ed:1991;Academic Press, San Diego, California.
42. Herbert T.C., Cohen S. Stress and immunity in humans. a meta-analytic review Psychosom Med. 55:1993;364-369.
43. Gruzelier J., Clow A., Evans P., Lazar I., Walker L.G. Mind-body influences on immunity. lateralised control, stress, individual difference predictors and prophylaxis Ann NY Acad Sci. 851:1998;487-494.
44. Walker L.G., Johnson V.C., Eremin O. Modulation of the immune response to stress by hypnosis and relaxation training in normals. a critical review Contemp Hypnos. 10:1993;19-27.
45. Wilson S.C., Barber T.X. The Creative Imagination Scale as a measure of hypnotic responsiveness. applications to experimental and clinical hypnosis Am J Clin Hypnos. 20:1978;235-249.
46. Johnson V.C., Walker L.G., Whiting P., Heys S.D., Eremin O. Can relaxation training and hypnotherapy modify the immune response to acute stress, and is hypnotisability relevant? Contemp Hypnos. 13:1996;100-108.
47. Walker L.G., Walker M.B., Ogston K., Heys S.D., Ah-See A.K., Miller I.D., Hutcheon A.W., Sarkar T.K., Eremin O. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer. 80:1999;262-268.
48. Walker L.G., Walker M.B., Simpson E., Fielden S., Ogston K., Segar A., Heys S.D., Ah-See A.K., Hutcheon A.W., Eremin O. Guided imagery and relaxation therapy can modify host defences in women receiving treatment for locally advanced breast cancer. Br J Surg. 84(suppl 1):1997;31.
49. Walker LG, Ogston K, Heys SD, Ah-See AK, Hutcheon AW, Eremin O. Psychological factors can predict response to primary chemotherapy in women with locally advanced breast cancer. Eur J Can (in press).
50. Addington-Hall J.M., MacDonald L.D., Anderson H.R. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer. 62:1990;695-699.
51. Coates A., Gebski V., Signorini D.et al. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol. 10:1992;1833-1838.
52. Coates A., Porzsolt F., Osoba D. Quality of life in oncology practice. prognostic value or EORTC QLQ-C30 scores in patients with advanced malignancy Eur J Cancer. 33:1997;1025-1030.
53. Earlam S., Glover C., Fordy C., Burke D., Allen-Mersh T.G. Relation between tumour size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol. 14:1996;171-175.
54. Fraser S.C.A., Ramirez A.J., Ebbs S.R.et al. A daily diary for quality of life measurement in advanced breast cancer trials. Br J Cancer. 67:1993;341-346.
55. Morris J.N., Sherwood S. Quality of life of cancer patients at different stages of the disease trajectory. J Chronic Dis. 40:1987;545-553.
56. Walker L.G., Walker M.B., Ogston K.et al. Can the Type C personality be modified by relaxation therapy and guided imagery? Psycho-Oncol. 7:1998;66-67.
57. Meyer T.J., Mark M.M. Effects of psychosocial interventions with adult cancer patients. a meta-analysis of randomised experiments Health Psychol. 14:1995;101-108.